Rifasutenizol not checked
TenNor Therapeutics (Suzhou) Limited · TNP-2198 · TNP-2198 capsules
FollowEvery change as it happens, and a Monday email
Stage
No active trials
Next date
None yet
Trials
0 active
7 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “400 mg, BID, taken orally within half an hour after breakfast and dinner.”In the company’s words, NCT05857163 on ClinicalTrials.gov
- Tested for
- Helicobacter Pylori Infection (6 trials), H.Pylori Infection
- Main trialPhase 3
- “A multi-center, randomized, double-blind, bismuth-containing quadruple active comparator-controlled Phase 3 clinical study to evaluate the efficacy and safety of Rifasutenizol in combination with rabeprazole and amoxicillin in the primary treatment of participants with H. pylori infection using an adaptive design with sample size re-estimation.”In the company’s words, NCT05857163 on ClinicalTrials.gov
- Other names
- TNP-2198 · TNP-2198 capsules
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials7
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Completed | 24 Dec 2023 | Efficacy and Safety of Rifasutenizol (TNP 2198), Rabeprazole and Amoxicillin in Participants With H. Pylori Infection | |
| Phase 2Completed | 20 Sep 2022 | Efficacy and Safety After Multiple Doses of TNP-2198 Capsules, Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules in Helicobacter Pylori Infected-positive Participants | |
| Phase 1/2Completed | 6 Jan 2022 | A Study to Evaluate Preliminary Helicobacter Pylori Eradication After Multiple Doses of TNP-2198 Capsules Combined With Rabeprazole Sodium Enteric-coated Tablets, or Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules | |
| Phase 1Completed | 18 Sep 2019 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effect of TNP-2198 Capsules After Single Oral Dose in Healthy Participants | |
| Phase 1Completed | 15 Jul 2021 | A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TNP-2198 Capsules in Asymptomatic Participants With Helicobacter Pylori Infection | |
| Phase 1Completed | 1 Sep 2022 | Human Mass Balance and Biotransformation Study of [14C]TNP-2198 | |
| Phase 1Completed | 14 Oct 2024 | Drug-Drug Interactions Between TNP-2198 and Midazolam, Clarithromycin |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 20 Nov 2026 · EU trials register (CTIS) updated 20 Nov 2026 · openFDA updated 20 Nov 2026